Nom du produit:4-(3-bromo-4-fluorophenyl)-3-[4-(2-methylsulfanylethylamino)-1,2,5-oxadiazol-3-yl]-1,2,4-oxadiazol-5-one

IUPAC Name:4-(3-bromo-4-fluorophenyl)-3-(4-{[2-(methylsulfanyl)ethyl]amino}-1,2,5-oxadiazol-3-yl)-4,5-dihydro-1,2,4-oxadiazol-5-one

CAS:1888341-29-4
Formule moléculaire:C13H11BrFN5O3S
Pureté:98%
Numéro de catalogue:CM607293
Poids moléculaire:416.23

Unité d'emballage Stock disponible Prix($) Quantité

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:1888341-29-4
Formule moléculaire:C13H11BrFN5O3S
Point de fusion:-
Code SMILES:CSCCNC1=NON=C1C1=NOC(=O)N1C1=CC(Br)=C(F)C=C1
Densité:
Numéro de catalogue:CM607293
Poids moléculaire:416.23
Point d'ébullition:
N° Mdl:
Stockage:

Category Infos

Furazans
Incorporation of heterocycles into drug molecules can enhance physical properties and biological activity. Oxadiazoles are a class of five-membered heterocycles containing one oxygen and two nitrogen atoms with special biological activity and thermodynamic properties. 1,2,4- and 1,3,4-oxadiazoles are widely used in the development of bioactive molecules, but 1,2,5-oxadiazoles (furazans) are used relatively sparingly. Compared with 1,2,4- and 1,3,4-isomers, 1,2,5-oxadiazole has unique physicochemical properties and electronic effects. The furazan ring has a strong inductive effect, comparable to that of trifluoromethyl or tetrazolyl. The unique properties of furoxan can confer specific pharmacological activities to drug-like molecules.